#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLseminars: Targeting lineage plasticity in prostate cancer

Drug resistance in cancer is often linked to changes in tumor cell state or lineage, but the…

Read More

#IDIBELLfellows: Laia Solé

Exploring the role of CDK8 in Young and Aged Hematopoietic Stem Cells: Expression, Kinase Activity, and Epigenetic…

Read More

Thesis: Association between (poly)phenols and obesity: from the observational study to the clinical trial

Thesis: Association between (poly)phenols and obesity: from the observational study to the clinical trial by Mercedes Gil-Lespinard…

Read More

Jornada Científica Anual de la Unitat Funcional de Pulmó (UFP) 2024

de l’Hospital Universitari de Bellvitge i l’Institut Català d’Oncologia Reunió científica multidisciplinar de la Unitat Funcional de…

Read More


Barcelona, June 27th-28th, 2024 Organizers: Victoria Campuzano, Gustavo Egea, Isabel Fabregat FREE REGISTRATION! Limited number of attendees:…

Read More

#IDIBELLseminars: An integrated approach, combining clinical science, machine learning and computational modelling, to understand congenital heart disease

Rare cardiovascular diseases, such as congenital heart disease, are difficult to study given that very few patients…

Read More

Thesis: Characterization of the 40S-LARP1 complex in a model of ribosome biogenesis-addicted tumors

Thesis: Characterization of the 40S-LARP1 complex in a model of ribosome biogenesis-addicted tumors By Carolina Martinez Herraez…

Read More

Càncer, no em fas por

Ponència a càrrec de Carla Roca Grau, investigadora del grup de recerca en Càncer hereditari de l’IDIBELL. 21…

Read More

Accelerator Meeting Point 2024: Bridging Borders in innovation

Bridging borders in innovation Vine a la nova edició de l’#AMP2024, el lloc on saber més sobre…

Read More

Bedside to Bench to Curbside: Addressing Breast Cancer Health Disparities

#IDIBELLextraordinaryseminar I will present – 1. aspects of cancer health disparities related to aggressive and rare breast…

Read More
Scroll to Top